Ferenc Darvas, Ph.D.

Executive Chairman of the Board, Founder

Prof. Ferenc Darvas acquired his degrees in Budapest, Hungary (medical chemistry MS, computer sciences BS, PhD in experimental biology). He has been teaching in Hungary, Spain, Austria, and in the USA. Dr. Darvas has been involved in introducing microfluidics/flow chemistry methodologies for synthetizing drug candidates since the late 90’s, which led him to found ThalesNano, the inventor of H-Cube®. Awarded twice with R&D100 (“Technical Oscar”).

Dr. Darvas was awarded Senator Honoris Cause by the University of Szeged, Hungary (2019), and as Fellow of the American Chemical Society (2016). Dr. Darvas is also the founder and active President of the Flow Chemistry Society, Switzerland, founder and Editorial Board member of the Journal of Flow Chemistry, founder of the Space Chemistry Consortium, organizer of the Space Chemistry Symposium series at ACS, and initiator of the world-first anti-Covid drug discovery experiments on ISS.

Richard Jones M. Sci

Board member

Richard joined InnoStudio as CEO in 2017. He has  since left to become CEO and Co-Founder of ThalesNano Energy Inc, but continues to operate as a board member. Before this, Richard was CEO of ThalesNano where he completely overhauled the product line, doubling the number of new instruments and greatly extending the number of countries ThalesNano sells into.

He joined ThalesNano in 2004 where he started as Chief Research Chemist, helping to develop the chemistry on the H-Cube® and other flow reactors. He then went on to become Product Manager of the R&D 100 Award winning H-Cube® before becoming Director of Product Management.

Prior to ThalesNano, Richard was at Biofocus Discovery and worked on the synthesis of several Kinase and GPCR inhibitor based compound libraries. Richard studied chemistry at the University of Bristol where he graduated with honors in 1999. He has over 20 scientific papers, books, and patents specializing in flow chemistry to his name.

Balázs Buchholcz, Ph.D.


Dr. Buchholcz Balázs obtained his M.Sc (2015) and Ph.D. (2018) in nanotechnology and materials science from the University of Szeged. He spent a year in the academic sphere as a researcher in Szeged and Budapest then joined the board of Innostudio in 2019. He is managing the nanotechnology and space chemistry laboratory, focusing on the application and development of state-of-the-art technology solutions.

He is an author or co-author of 6 scientific papers and book chapters and a reviewer in 3 scientific journals.

Szilvia Gilmore

Chief Business Officer

Ms. Gilmore received her degree in economics, then went on to have a career in trade and industry. She joined the Darholding company network in 2007 where she has held various positions. Szilvia received a degree in Intellectual Properties in 2011 and was promoted to Chief Intellectual Property Officer. She is currently responsible for all operational aspects of the company, including corporate and business development activities, strategic planning, budget development and control, participating in the development of strategic partnerships, joint ventures and alliances, as well as platform technology and intellectual licensing opportunities. Since 2015 she also fulfils the Chief Operating Officer role at AgroThetis, a unique agrochemical nanoformulation technology company and is the Assistant Director of the Flow Chemistry Society, Switzerland.

Georg Petroianu

Board member

Dr. Georg Petroianu, a longtime educator and researcher presently serves as Professor & Chair of the Department of Pharmacology & Therapeutics at Khalifa University College of Medicine and as Associate Dean for Research. He was tenured Chairman of the Department of Cellular Biology & Pharmacology at the Herbert Wertheim College of Medicine, Florida International University, in the United States.

He has authored more than 180 peer-reviewed research papers, some 60 other non-abstracted publications and several books. For his contribution to pharmacology, Dr. Petroianu was awarded an honorary fellowship and the Issekutz Medal of the Hungarian Society of Pharmacology and Toxicology, an honorary doctoral degree from Semmelweis University (Budapest) and an honorary fellowship of the Faculty of Occupational Medicine of the Royal College of Physicians of Ireland. Most recently, he was inducted in the Academy of Pharmacology Educators (FAPE) hosted by ASPET.

Dr. Petroianu has been serving on Innostudio’s Board since 2016.

Gergo Mezohegyi, Ph.D.

Head of Space Chemistry Division

Gergo joined InnoStudio in 2019 and took the role of developing, coordinating and implementing R+D+I projects at the field of space chemistry. He contributed to receiving national and international grants for projects with the aim of developing flow chemical equipments for microgravity applications. He supports building international strategic partnerships and business development.

Gergo obtained his Ph.D. in chemical and process engineering at the University Rovira i Virgili (2010), and completed postdoctoral researches at the Catholic University of Leuven and the Slovenian National Institute of Chemistry, within the topics of innovative reactor development for water and wastewater treatment.

Prior to InnoStudio, he established the R&D division and managed both industrial & research projects at Inwatech Environmental Ltd. He is author of 8 scientific papers.

Upcoming Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Social Media

Follow our daily updated Social Media pages for the latest news, event,curiosities and fun.

Latest News & Events

Latest Articles

InnoStudio cited in the lead space journal by Roscosmos

InnoStudio cited in the lead space journal by Roscosmos

The recent and successful study of InnoStudio and CycloLab for COVID-19 drug research in space has been gaining attention and receiving positive feedback worldwide. The Roscosmos State Corporation for Space Activities found our idea and experiment valuable enough to...

COVID-19 drug research and bio-mining launching to Space Station

COVID-19 drug research and bio-mining launching to Space Station

For the past 20 years, astronauts have been performing experiments on the International Space Station. Science in low Earth orbit is not only hugely important in preparation for continued space exploration, the research also benefits life on Earth. We’ve seen...